Combined Shareholders’ Meeting of 28 May 2019 - Global
Skip to main content
Combined Shareholders’ Meeting of 28 May 2019
Press shift tab to select search category

Loading...
  • Newsroom  arrow down
    < Back
    • Press Releases
    • Media Updates
    • Media Library
    • Contacts

    • Subscribe
    • Our 2023 Integrated Annual Report is live!

      Featured Image
  • Investors arrow down
      < Back
    • Investors
    • Investors
    • Financial Results
    • Annual Reports & Accounts
    • Investor Events
    • Financial Calendar
    • Corporate News
    • Regulated Information
    • Shareholder Information
    • Contacts
    • Subscribe
  • Careers arrow down
      < Back
    • Careers
    • Careers
    • Working at Ipsen
    • Culture
    • Job Search
  • Contacts arrow down
      < Back
    • Contacts
    • Contacts
    • Locations
    • Adverse Event Reporting
    • Subscribe
  • Press shift tab to select search category

    Loading...
  • English  EN     Français  FR     EN  arrow_down
    • English EN
    • Français FR
  • Global Global
    < Back
    • Global EN FR
    • Annual Report EN FR
    • Americas
    • Asia Pacific
    • Europe
    • Middle East & Africa
    • United States
    • Brazil
    • Canada
    • Mexico
    • Australia
    • China
    • Singapore
    • South Korea
    • Japan
    • Belgium
    • Ukraine
    • UK
    • Germany
    • France
    • Nordics
    • Greece
    • Italy
    • Netherlands
    • Spain
    • Poland
    • Russia
    • Czech Republic
    • Austria
    • Switzerland
    • UAE & Gulf
  • Home
  • Company
      < Back
    • Company
    • Company
    • Leadership
    • History
    • Fondation Ipsen
  • Expertise
      < Back
    • Expertise
    • Oncology
    • Rare Disease
    • Neuroscience
    • Medicines
  • Science
      < Back
    • Science
    • Science
        < Back
      • Science
      • Oncology
      • Rare Disease
      • Neuroscience
    • Profiles
    • Clinical Trials
        < Back
      • Clinical Trials
      • Lay Summaries
      • Find Clinical Trials
    • Partnering
        < Back
      • Partnering
      • Therapeutic focus
      • Meet the team
    • Pipeline
  • Sustainability
      < Back
    • Sustainability
    • Sustainability
    • Environment
    • Patients
    • People
    • Governance
    • Our Standards
  • Patients
      < Back
    • Patients
    • Patients
    • Together for Oncology
    • Together for Rare Disease
    • Together for Neuroscience
    • Collaborate with us
  • Stories
  1. Home
  2. Press Releases
  3. Shareholders Meeting press releases

Combined Shareholders’ Meeting of 28 May 2019

Post navigation

Previous
Next

Combined Shareholders’ Meeting of 28 May 2019

Combined Shareholders’ Meeting of 28 May 2019

- 17 April 2019 - 0 mins read

Post navigation

Previous
Next
Share this on social media
  • Share on LinkedIn
  • Share on Facebook

Related Press Releases

Ipsen S.A. – Annual General Meeting held on 21 May 2025
21 May 2025 5 mins read

Ipsen S.A. – Annual General Meeting held on 21 May 2025

Ipsen S.A. – Formalities for making available and consulting preparatory documents to the 2025 Annual General Meeting
30 April 2025 5 mins read

Ipsen S.A. – Formalities for making available and consulting preparatory documents to the 2025 Annual General Meeting

30 August 2024 1 mins read

Testing video 1

30 August 2024 1 mins read

Testing video 3

30 August 2024 1 mins read

Testing video 2

Annual General Meeting of Ipsen S.A. held on 28 May 2024
28 May 2024 2 mins read

Annual General Meeting of Ipsen S.A. held on 28 May 2024

IPSEN – 2022 SM – Voting results and replay
03 June 2022 0 mins read

IPSEN – 2022 SM – Voting results and replay

Ipsen – 2021 SM – Results and replay – 31 May 2021
09 June 2021 0 mins read

Ipsen – 2021 SM – Results and replay – 31 May 2021

Combined Shareholders’ Meeting of 27 May 2021
05 May 2021 0 mins read

Combined Shareholders’ Meeting of 27 May 2021

Combined Shareholders’ Meeting of 29 May 2020
07 May 2020 0 mins read

Combined Shareholders’ Meeting of 29 May 2020

IPN price

€121.00

 €-1.40 (-1.14%)

  • Adverse Event Reporting
  • Annual Report
  • Locations
  • Contacts

Ipsen logo
LinkedIn Instagram Facebook Youtube
  • Contacts
  • Terms & Conditions
  • Cookie Policy
  • Privacy Policy

Copyright © Ipsen Pharma. All rights reserved - 2024

You are now leaving the Ipsen group website.
To continue, please click on Continue?

Continue
This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.